Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Asian Pac J Cancer Prev ; 25(6): 1863-1867, 2024 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-38918645

RESUMO

OBJECTIVE: There have been several reports on rechallenge with docetaxel, cabazitaxel, abiraterone acetate, or ethinylestradiol for metastatic castration-resistant prostate cancer (mCRPC). However, the efficacy of enzalutamide rechallenge for mCRPC has not been evaluated. METHODS: We retrospectively reviewed 63 consecutive patients who received enzalutamide for mCRPC at our institution between 2014 and 2022. Eight of these patients underwent rechallenge with enzalutamide after disease progression on prior enzalutamide and other therapy and were the focus of this study. The prostate-specific antigen (PSA) response (PSA decrease >50%), PSA progression-free survival, treatment duration, overall survival (OS) after CRPC, and treatment-related adverse events were evaluated. RESULTS: PSA decline to enzalutamide rechallenge was observed in 6 patients (75%), of which 2 patients had a PSA response. The median treatment duration was 4 months (range 1-12) and median PSA progression-free survival was 3 months (range 1-7). Median OS after CRPC was 41 months. OS after CRPC was not increased in patients with a PSA response. No toxicities were worse than grade ≥3. CONCLUSION: Enzalutamide rechallenge achieved a PSA response in a quarter of our patients with mCRPC after disease progression on prior enzalutamide. However, no improvement of OS was identified in these patients.


Assuntos
Benzamidas , Nitrilas , Feniltioidantoína , Antígeno Prostático Específico , Neoplasias de Próstata Resistentes à Castração , Humanos , Masculino , Neoplasias de Próstata Resistentes à Castração/tratamento farmacológico , Neoplasias de Próstata Resistentes à Castração/patologia , Neoplasias de Próstata Resistentes à Castração/mortalidade , Feniltioidantoína/uso terapêutico , Feniltioidantoína/administração & dosagem , Estudos Retrospectivos , Idoso , Pessoa de Meia-Idade , Antígeno Prostático Específico/sangue , Seguimentos , Taxa de Sobrevida , Prognóstico , Idoso de 80 Anos ou mais , Antineoplásicos/uso terapêutico
2.
Nihon Hinyokika Gakkai Zasshi ; 114(2): 57-60, 2023.
Artigo em Japonês | MEDLINE | ID: mdl-38644187

RESUMO

A 63-year-old man visited our hospital with a complaint of penile swelling caused by metallic ring entrapment in the penis. He had put the ring around his penis 4 hours prior and was subsequently unable to remove it. We attempted to remove the ring using a ring cutter but that was unsuccessful. We then inserted two 18 G needles into the corpus cavernosum through the glans penis and removed blood by manual compression according to a technique called the "string method." The swelling gradually decreased, and we successfully removed the ring without destroying it. The total duration of strangulation was about 5 hours. The patient was subsequently discharged after ensuring he had no urinary difficulties. No complications were observed during the follow-up period.In almost all penile strangulation cases caused by hard objects, such as metallic rings, reported in Japan, the objects were typically destroyed and penile puncture and blood removal, as was performed in our case, was rare. Although penile puncture and blood removal is not commonly performed in Japan, this technique can be performed quickly and inexpensively in the emergency room and should be considered an initial treatment for penile strangulation caused by hard objects.


Assuntos
Pênis , Humanos , Masculino , Pessoa de Meia-Idade , Pênis/lesões , Pênis/cirurgia , Punções , Corpos Estranhos/cirurgia , Resultado do Tratamento , Doenças do Pênis/cirurgia , Doenças do Pênis/etiologia , Constrição Patológica/cirurgia , Constrição Patológica/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...